Dr. Amama Sadiq Promoted to New Role as Medical Director at Clarion
Clarion is pleased to announce that Amama Sadiq, MD, MPH, has been promoted to the newly created role of Medical Director. In this role, Dr. Sadiq will provide specific medical and clinical insights and guidance across Clarion projects as well as help the firm identify and respond to health industry evolutionary forces critical to our clients’ success.
Before joining Clarion in 2014, Dr. Sadiq practiced Internal Medicine in London where she received subspecialty training in GI and hepatology and developed a lifelong passion to advance care and treatment of liver disorders including NAFLD and hepatitis. Dr. Sadiq has also earned an MPH in Health Policy and Management from Harvard, which—combined with her International Health Care Systems experience—provides her with a uniquely multi-faceted knowledge base for Clarion’s global clients.
“Amama’s knowledge, skills, and experience converge in her role as Medical Director at Clarion, creating value along many dimensions for our clients and for Clarion,” said Tom Murtagh, Managing Director. “Her years in the clinic treating patients, combined with her innovative research, public health expertise, and clinical research experiences will offer insight into the priorities of many important stakeholders for biopharma companies.”
“I’m thrilled with this new opportunity,” stated Dr. Sadiq. “I derive tremendous satisfaction working with clients to help them bring novel therapies to patients, and serving as Clarion’s Medical Director allows me to apply more deeply the knowledge I gained from my many years of training and providing care as a physician, a researcher, and a public health professional.”